Short Interest in Vivos Inc. (OTCMKTS:RDGL) Increases By 25.7%

Vivos Inc. (OTCMKTS:RDGL) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 31,800 shares, an increase of 25.7% from the December 31st total of 25,300 shares. Based on an average daily volume of 3,697,700 shares, the short-interest ratio is currently 0.0 days.

Vivos Price Performance

Shares of OTCMKTS:RDGL opened at $0.12 on Monday. The stock’s 50-day moving average is $0.11 and its 200 day moving average is $0.13. The company has a market cap of $52.46 million, a PE ratio of -11.90 and a beta of 0.91. Vivos has a 1 year low of $0.05 and a 1 year high of $0.26.

About Vivos

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.